Safety of Intranasal Esketamine Administration in Brugada Syndrome

Aurélie Bobet, Antoine Yrondi, Anne Rollin, Racan Abidine, François Montastruc, Tanguy Taillefer de Laportaliere

Open source

DOI
10.1097/jcp.0000000000002144
Published
2026-03-03
Container
Journal of Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/jcp.0000000000002144,
  title = {Safety of Intranasal Esketamine Administration in Brugada Syndrome},
  author = {Aurélie Bobet and Antoine Yrondi and Anne Rollin and Racan Abidine and François Montastruc and Tanguy Taillefer de Laportaliere},
  year = {2026},
  journal = {Journal of Clinical Psychopharmacology},
  doi = {10.1097/jcp.0000000000002144},
  url = {https://doi.org/10.1097/jcp.0000000000002144}
}

RIS

TY  - JOUR
TI  - Safety of Intranasal Esketamine Administration in Brugada Syndrome
AU  - Aurélie Bobet
AU  - Antoine Yrondi
AU  - Anne Rollin
AU  - Racan Abidine
AU  - François Montastruc
AU  - Tanguy Taillefer de Laportaliere
PY  - 2026
JO  - Journal of Clinical Psychopharmacology
DO  - 10.1097/jcp.0000000000002144
UR  - https://doi.org/10.1097/jcp.0000000000002144
ER  - 

APA

Bobet, A., Yrondi, A., Rollin, A., Abidine, R., Montastruc, F., & Laportaliere, T. T. D. (2026). Safety of Intranasal Esketamine Administration in Brugada Syndrome. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000002144

Source records